凯尼克萨制药 KNSA
$93.86 +$5.52 (+6.25%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $95.00 +1.21%
开盘$88.92
昨收$88.34
当日区间$88.41 – $94.48
成交量636.3K
市值$7.37B
市盈率（TTM）71.1
股息率–
分析师观点
一致评级买入
分析师人数5
平均目标价$106.20+13.1% 较现价
- 买入 100%
最低 $98.00现价 $93.86均值 $106.20最高 $122.00
最新评级变动
已记录的最近20次评级动作给出的目标价区间为$57.00至$122.00，平均为$90.10。
| 日期 | 机构 | 评级 | 目标价 |
|---|---|---|---|
| 30 Oct 2026 | J.P. Morgan | BUY | $122.00 |
| 28 Oct 2026 | CCORF | BUY | $98.00 |
| 28 Oct 2026 | Wells Fargo | BUY | $110.00 |
| 27 Oct 2026 | Goldman Sachs | BUY | $101.00 |
| 23 Oct 2026 | CCORF | BUY | $98.00 |
| 15 Oct 2026 | Citi | BUY | $100.00 |
| 29 Sep 2026 | Wells Fargo | BUY | $87.00 |
| 12 Aug 2026 | CCORF | BUY | $98.00 |
| 30 Jul 2026 | Goldman Sachs | BUY | $90.00 |
| 29 Jul 2026 | CCORF | BUY | $98.00 |
| 29 Jul 2026 | Citi | BUY | $100.00 |
| 29 Jul 2026 | J.P. Morgan | BUY | $107.00 |
| 28 Jul 2026 | TD Cowen | BUY | $95.00 |
| 28 Jul 2026 | Wedbush | BUY | $99.00 |
| 23 Jul 2026 | Goldman Sachs | BUY | $75.00 |
| 29 Jun 2026 | Wedbush | BUY | $72.00 |
| 4 May 2026 | J.P. Morgan | BUY | $72.00 |
| 29 Apr 2026 | CCORF | BUY | $64.00 |
| 29 Apr 2026 | Wells Fargo | BUY | $57.00 |
| 29 Apr 2026 | Wedbush | BUY | $59.00 |
暂无评论——快来第一个聊聊 KNSA。